Variant Bio Appoints Craig T. Basson, MD, PhD, to Advance Genomics-Driven Clinical Programs
/PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer...
prnewswire.com